- In 2018, the FDA granted breakthrough designation to the MI assay in DISCERN and FDA review is pending.

 - DISCERN test is covered by and paid for by Medicare Fee-for Service. 

 - DISCERN test has been awarded two unique CPT (PLA) codes 206U (MI & PKC) diagnostic tests and 207U (AD index) confirmatory test.